Black Rock Inc. Atea Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,243,306 shares of AVIR stock, worth $30.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,243,306

Previous 9,443,887 2.12%

Holding current value

$30.6 Million

Previous $28.8 Million 29.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.09 - $4.56 $619,795 - $914,649	-200,581 Reduced 2.12%	9,243,306 $37.3 Million
Q4 2023 Feb 13, 2024	BUY	$2.8 - $3.35 $3.51 Million - $4.2 Million	1,252,385 Added 15.29%	9,443,887 $28.8 Million
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $1.45 Million - $1.83 Million	482,789 Added 6.26%	8,191,502 $24.6 Million
Q2 2023 Aug 11, 2023	SELL	$3.21 - $5.06 $1.07 Million - $1.69 Million	-333,023 Reduced 4.14%	7,708,713 $28.8 Million
Q1 2023 May 12, 2023	BUY	$3.0 - $4.97 $24,492 - $40,575	8,164 Added 0.1%	8,041,736 $26.9 Million

Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $706,661 - $1 Million	162,451 Added 2.06%	8,033,572 $38.6 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $2.55 Million - $4.07 Million	463,579 Added 6.26%	7,871,121 $44.8 Million
Q2 2022 Aug 12, 2022	BUY	$5.33 - $8.18 $4.17 Million - $6.4 Million	782,849 Added 11.82%	7,407,542 $52.6 Million
Q1 2022 May 12, 2022	BUY	$5.5 - $9.19 $4.64 Million - $7.75 Million	843,496 Added 14.59%	6,624,693 $47.8 Million
Q4 2021 Feb 10, 2022	BUY	$7.67 - $44.59 $12.6 Million - $73.3 Million	1,644,396 Added 39.75%	5,781,197 $51.7 Million
Q3 2021 Nov 09, 2021	BUY	$21.33 - $35.06 $13.8 Million - $22.6 Million	645,838 Added 18.5%	4,136,801 $145 Million
Q2 2021 Aug 11, 2021	BUY	$19.22 - $59.08 $67.1 Million - $206 Million	3,490,963 New	3,490,963 $75 Million

Others Institutions Holding AVIR

# of Institutions

119

Shares Held

49.6M

Call Options Held

108K

Put Options Held

327K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $276M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account